Clinical Trials

32 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

NCT02718833 2026-01-22

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

52 enrolled

Multiple Myeloma, Recurrence

NCT07361133 2026-01-22

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

120 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT07348393 2026-01-16

Mezi-KD

70 enrolled

Multiple Myeloma, Recurrence

NCT05922501 2026-01-14

ISABELA

50 enrolled

Multiple Myeloma, Recurrence

NCT07340164 2026-01-14

TROY

116 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT07337421 2026-01-13

Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors

30 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT07337460 2026-01-13

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

30 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT04326257 2026-01-08

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Phase 2 Completed

20 enrolled 13 charts

Head & Neck

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT05199051 2026-01-05

AGORA-1

Other hematologic neoplasm

19 enrolled

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT02286687 2026-01-02

Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes

150 enrolled

Neoplasm Metastasis, Neoplasms, Recurrence

NCT06232655 2025-12-19

Cladribine Venetoclax in Monocytic AML

Other hematologic neoplasm

20 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT06827860 2025-12-18

Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

23 enrolled

Multiple Myeloma, Recurrence

NCT02151084 2025-12-16

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

57 enrolled

Gallbladder Neoplasms, Recurrence

NCT04204850 2025-12-03

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

20 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT06300528 2025-12-03

Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas

27 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03618550 2025-12-02

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

257 enrolled

Lymphoid

Hodgkin Disease, Recurrence

NCT03999710 2025-11-28

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

61 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Recurrence

NCT07254754 2025-11-28

LATE-R-GEL-23

45 enrolled

Lymphoid

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03734198 2025-11-26

IDA53

LymphoidOther hematologic neoplasm

29 enrolled

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02244125 2025-11-24

PCD

Phase 2 Completed

100 enrolled

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT05704829 2025-11-19

ADAPTHER2-IV

402 enrolled

Recurrence

NCT01068249 2025-11-18

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

42 enrolled 11 charts

Gynecologic

Recurrence, Endometrial Neoplasms

NCT06421675 2025-11-14

EMBRACE

40 enrolled

Cytokine Release Syndrome, Multiple Myeloma, Recurrence

NCT03557359 2025-11-03

Nivolumab for Recurrent or Progressive IDH Mutant Gliomas

Phase 2 Completed

35 enrolled 9 charts

CNS

Glioma, Recurrence

NCT05911321 2025-10-20

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

6 enrolled